Last reviewed · How we verify
NCT03322176
Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing
trial testing Genetic testing in Colon Cancer in 200 participants. Status unknown.
17 October 2020
Quick facts
| Lead sponsor | Data Collection Analysis Business Management |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 17 October 2017 |
| Primary completion | 17 October 2020 |
| Estimated completion | 1 November 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Genetic testing
Conditions studied
- Colon Cancer — all drugs for Colon Cancer →
- Endometrial Cancer — all drugs for Endometrial Cancer →
Sponsor
Data Collection Analysis Business Management
Who can join
Adults 18 to 64, any sex, with Colon Cancer or Endometrial Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Increase surveillance for LYNCH Syndrome
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03322176
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Genetic testing
Trials testing the same drug.
- NCT06974357 — Evaluation of Genetic Abnormalities Amongst Calcium Phosphate Stone Formers · NA · recruiting
- NCT06632977 — Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial · Phase 2 · recruiting
- NCT06862063 — Next Generation Sequencing Analysis of Patients with Spontaneous Dissection of Cervical Arteries · NA · recruiting
- NCT05437588 — Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolesce · NA · recruiting
- NCT04354675 — Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer · NA · completed
Other recruiting trials for Colon Cancer
Currently open trials in the same condition.
- NCT06923787 — Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patient · Phase 2 · recruiting
- NCT07279077 — Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advance · Phase 2 · recruiting
- NCT07205965 — The Effect of Acceptance and Commitment Approach-Based Psychoeducation in Cancer Survivors · NA · active not recruiting
- NCT07285356 — Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy · NA · recruiting
- NCT07161713 — SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors · NA · recruiting
Other Data Collection Analysis Business Management trials
Trials by the same sponsor.
- NCT03768011 — Subjective Observational Study of Patients Using Transdermal Cream Medication And/Or Transdermal Patches With Or Without · unknown
- NCT03781024 — A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care · unknown
- NCT03322254 — How Respiratory Pathogens Panel Results Affect Patients' Plan of Care · unknown
- NCT03319290 — Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategi · unknown
- NCT03322241 — Increase Surveillance for Wellness Decisions, Also to Determine Targeted Risk-reducing and Preventative Strategies · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03322176 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Data Collection Analysis Business Management
- Last refreshed: 23 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03322176.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing